Author
Listed:
- Guang-Hui Liu
(National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences
Gene Expression Laboratory, Salk Institute for Biological Studies
Beijing Institute for Brain Disorders)
- Keiichiro Suzuki
(Gene Expression Laboratory, Salk Institute for Biological Studies)
- Mo Li
(Gene Expression Laboratory, Salk Institute for Biological Studies)
- Jing Qu
(Laboratory of RNA Biology, Institute of Biophysics, Chinese Academy of Sciences)
- Nuria Montserrat
(Center for Regenerative Medicine in Barcelona)
- Carolina Tarantino
(Center for Regenerative Medicine in Barcelona)
- Ying Gu
(Gene Expression Laboratory, Salk Institute for Biological Studies)
- Fei Yi
(Gene Expression Laboratory, Salk Institute for Biological Studies)
- Xiuling Xu
(National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences)
- Weiqi Zhang
(National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences)
- Sergio Ruiz
(Gene Expression Laboratory, Salk Institute for Biological Studies)
- Nongluk Plongthongkum
(University of California at San Diego)
- Kun Zhang
(University of California at San Diego)
- Shigeo Masuda
(Gene Expression Laboratory, Salk Institute for Biological Studies)
- Emmanuel Nivet
(Gene Expression Laboratory, Salk Institute for Biological Studies)
- Yuji Tsunekawa
(Gene Expression Laboratory, Salk Institute for Biological Studies)
- Rupa Devi Soligalla
(Gene Expression Laboratory, Salk Institute for Biological Studies)
- April Goebl
(Gene Expression Laboratory, Salk Institute for Biological Studies)
- Emi Aizawa
(Gene Expression Laboratory, Salk Institute for Biological Studies)
- Na Young Kim
(Gene Expression Laboratory, Salk Institute for Biological Studies)
- Jessica Kim
(Gene Expression Laboratory, Salk Institute for Biological Studies)
- Ilir Dubova
(Gene Expression Laboratory, Salk Institute for Biological Studies)
- Ying Li
(National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences)
- Ruotong Ren
(National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences)
- Chris Benner
(Integrative Genomics and Bioinformatics Core, Salk Institute for Biological Studies)
- Antonio del Sol
(Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg)
- Juan Bueren
(Medioambientales y Tecnológicas (CIEMAT)/Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBER-ER)
Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM))
- Juan Pablo Trujillo
(Universitat Autonoma de Barcelona, Campus de Bellaterra s/n 08193 Bellaterra)
- Jordi Surralles
(Universitat Autonoma de Barcelona, Campus de Bellaterra s/n 08193 Bellaterra)
- Enrico Cappelli
(Clinical and Experimental Hematology Unit, G. Gaslini Children’s Hospital)
- Carlo Dufour
(Clinical and Experimental Hematology Unit, G. Gaslini Children’s Hospital)
- Concepcion Rodriguez Esteban
(Gene Expression Laboratory, Salk Institute for Biological Studies)
- Juan Carlos Izpisua Belmonte
(Gene Expression Laboratory, Salk Institute for Biological Studies)
Abstract
Fanconi anaemia (FA) is a recessive disorder characterized by genomic instability, congenital abnormalities, cancer predisposition and bone marrow (BM) failure. However, the pathogenesis of FA is not fully understood partly due to the limitations of current disease models. Here, we derive integration free-induced pluripotent stem cells (iPSCs) from an FA patient without genetic complementation and report in situ gene correction in FA–iPSCs as well as the generation of isogenic FANCA-deficient human embryonic stem cell (ESC) lines. FA cellular phenotypes are recapitulated in iPSCs/ESCs and their adult stem/progenitor cell derivatives. By using isogenic pathogenic mutation-free controls as well as cellular and genomic tools, our model serves to facilitate the discovery of novel disease features. We validate our model as a drug-screening platform by identifying several compounds that improve hematopoietic differentiation of FA–iPSCs. These compounds are also able to rescue the hematopoietic phenotype of FA patient BM cells.
Suggested Citation
Guang-Hui Liu & Keiichiro Suzuki & Mo Li & Jing Qu & Nuria Montserrat & Carolina Tarantino & Ying Gu & Fei Yi & Xiuling Xu & Weiqi Zhang & Sergio Ruiz & Nongluk Plongthongkum & Kun Zhang & Shigeo Masu, 2014.
"Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs,"
Nature Communications, Nature, vol. 5(1), pages 1-17, September.
Handle:
RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms5330
DOI: 10.1038/ncomms5330
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms5330. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.